Elena Giudice

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Endometrial Cancer

End Stage Renal Disease

Top Venues

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Nature communications

Cancer management and research

This page only lists publications with an associated author ORCID identifier.

Publications

Elena Giudice, Tzu-Ting Huang, Jayakumar R Nair, Grant Zurcher, Ann McCoy, Darryl Nousome, Marc R Radke, Elizabeth M Swisher, Stanley Lipkowitz, Kristen R Ibanez, Duncan Donohue, Tyler Malys, Min-Jung Lee, Bernadette Redd, Elliot Levy, Shraddha Rastogi, Nahoko Sato, Jane B Trepel, Jung-Min Lee
The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial. Nature communications 15 (1) (2024)
Elena Giudice, Tzu-Ting Huang, Jayakumar R Nair, Grant Zurcher, Ann McCoy, Darryl Nousome, Marc R Radke, Elizabeth M Swisher, Stanley Lipkowitz, Kristen R Ibanez, Duncan Donohue, Tyler Malys, Min-Jung Lee, Bernadette Redd, Elliot Levy, Shraddha Rastogi, Nahoko Sato, Jane B Trepel, Jung-Min Lee
The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial. Nature communications 15 (1) (2024)
Elena Giudice, Tzu-Ting Huang, Jayakumar R Nair, Grant Zurcher, Ann McCoy, Darryl Nousome, Marc R Radke, Elizabeth M Swisher, Stanley Lipkowitz, Kristen R Ibanez, Duncan Donohue, Tyler Malys, Min-Jung Lee, Bernadette Redd, Elliot Levy, Shraddha Rastogi, Nahoko Sato, Jane B Trepel, Jung-Min Lee
The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial. Nature communications 15 (1) (2024)
Vanda Salutari, Viola Ghizzoni, Maria Vittoria Carbone, Elena Giudice, Serena Cappuccio, Francesco Fanfani, Giovanni Scambia, Domenica Lorusso
Genome tumor profiling in endometrial cancer and clinical relevance in endometrial cancer management: a retrospective single-center experience. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Veronica Agostinelli, Lucia Musacchio, Floriana Camarda, Vanda Salutari, Maria Vittoria Carbone, Viola Ghizzoni, Camilla Nero, Caterina Ricci, Maria Teresa Perri, Elena Giudice, Sara Lardino, Rossana Berardi, Giovanni Scambia, Domenica Lorusso
Therapeutic Potential of Tisotumab Vedotin in the Treatment of Recurrent or Metastatic Cervical Cancer: A Short Report on the Emerging Data. Cancer management and research 15 (2023)
Lucia Musacchio, Serena Maria Boccia, Claudia Marchetti, Angelo Minucci, Floriana Camarda, Chiara Cassani, Jole Ventriglia, Vanda Salutari, Viola Ghizzoni, Elena Giudice, Maria Teresa Perri, Maria Vittoria Carbone, Caterina Ricci, Sandro Pignata, Anna Fagotti, Giovanni Scambia, Domenica Lorusso
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Elena Giudice, Vanda Salutari, Caterina Ricci, Camilla Nero, Maria Vittoria Carbone, Lucia Musacchio, Viola Ghizzoni, Maria Teresa Perri, Floriana Camarda, Francesca Tronconi, Domenica Lorusso, Giovanni Scambia
Recent progress in the use of pharmacotherapy for endometrial cancer. Expert opinion on pharmacotherapy (2022)
Elena Giudice, Marica Gentile, Vanda Salutari, Caterina Ricci, Lucia Musacchio, Maria Vittoria Carbone, Viola Ghizzoni, Floriana Camarda, Francesca Tronconi, Camilla Nero, Francesca Ciccarone, Giovanni Scambia, Domenica Lorusso
PARP Inhibitors Resistance: Mechanisms and Perspectives. Cancers 14 (6) (2022)
Camilla Nero, Francesca Tronconi, Elena Giudice, Giovanni Scambia, Domenica Lorusso
Management of stage III and IVa uterine cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 32 (3) (2022)